GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Return-on-Tangible-Equity

Gubra AS (CHIX:GUBRAC) Return-on-Tangible-Equity : -10.94% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Gubra AS's annualized net income for the quarter that ended in Dec. 2023 was kr-52.8 Mil. Gubra AS's average shareholder tangible equity for the quarter that ended in Dec. 2023 was kr482.2 Mil. Therefore, Gubra AS's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was -10.94%.

The historical rank and industry rank for Gubra AS's Return-on-Tangible-Equity or its related term are showing as below:

CHIX:GUBRAc' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -15.65   Med: 10.66   Max: 59.99
Current: -12.54

During the past 5 years, Gubra AS's highest Return-on-Tangible-Equity was 59.99%. The lowest was -15.65%. And the median was 10.66%.

CHIX:GUBRAc's Return-on-Tangible-Equity is ranked better than
72.55% of 1297 companies
in the Biotechnology industry
Industry Median: -47.16 vs CHIX:GUBRAc: -12.54

Gubra AS Return-on-Tangible-Equity Historical Data

The historical data trend for Gubra AS's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Return-on-Tangible-Equity Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
- 17.84 59.99 3.47 -15.65

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial - -9.28 22.13 -12.15 -10.94

Competitive Comparison of Gubra AS's Return-on-Tangible-Equity

For the Biotechnology subindustry, Gubra AS's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Gubra AS's Return-on-Tangible-Equity falls into.



Gubra AS Return-on-Tangible-Equity Calculation

Gubra AS's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-44.524/( (100.877+467.972 )/ 2 )
=-44.524/284.4245
=-15.65 %

Gubra AS's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-52.77/( (496.344+467.972)/ 2 )
=-52.77/482.158
=-10.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Gubra AS  (CHIX:GUBRAc) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Gubra AS Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Gubra AS's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (CHIX:GUBRAC) Business Description

Industry
Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (CHIX:GUBRAC) Headlines

No Headlines